FDA panel urges looser Avandia restrictions

In a reversal of its past position, a majority of a 26-person Food and Drug Administration advisory panel voted Thursday to recommend looser restrictions on the controversial diabetes drug Avandia.
Source: WDSU.com - Health - Category: Consumer Health News Source Type: news